|
|
RISK MANAGEMENT: Potential for Abuse
- Article from:
-
Pharmaceutical Executive
- Article date:
-
June 1, 2005
- Author:
-
|
Copyright informationCopyright Advanstar Communications, Inc. Jun 2005. Provided by ProQuest LLC. (Hide copyright information)
|
All too often, abuse liability and dependence potential are afterthoughts in the drug development process.
With diseases of the central nervous system affecting an estimated 50 million Americans each year, the pharma industry is harnessing an explosion of new compounds in development in this area. However, the search for new and efficacious medications for conditions such as anxiety, depression, pain, and ADHD is tempered by the potential public health impacts of abuse liability and dependence potential.
Indeed, in 2002, more than six million people in the United States reported using psychotherapeutic drugs for "non-medical" purposes at some time in their lives, according to the Substance ...